Article - Billing and Coding: Stem Cell Transplantation (A52879)

Jayne D, Passweg J, Marmont A, et al. European Group for Blood and Marrow Transplantation, European League Against Rheumatism Registry. Autologous stem cell transplantation for systemic lupu erythematous.Lupus.2004;13(3):168-176.Khouri IF, Saliba RM, Admirand J, et al. Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.Br J Haematol.2007;137(4):355-363.Kim MK, Kim S. Lee SS, et al. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.Ann Hematol.2007 Jun;86(6):435-442.Kiss TL, Mollee P, Lazarus HM, Lipton JH. Stem cell transplantation for mantle cell lymphoma: if, when and how?Bone Marrow Transplant.2005;36(8):655-661.Kurumagawa T, Seki S, Kobayashi H, et al. Characterization of bronchoalveolar lavage T cell subsets in sarcoidosis on the basis of CD57, CD4 and CD8.Clin Exp Immunol.2003;133(3):438-447.Lobeck L. Monitoring disease activity in multiple sclerosis.Landes Bioscience.2004:35.Loh Y, Oyama Y, Statkute L, et al. Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission.Bone Marrow Transplant.2007;40(1):47-53.Mehta N, Maragulia JC, Moskowitz A, et al. A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.Clin Lymphoma Myeloma Leuk.2013 Dec;13(6):664-670.Nademanee A, Palmer JM, Popplewell L, et al. High-dose therapy and autologous hematopoietic cell transplantation in the peripheral T cell lymphoma (PTCL): analysis of prognostic factors.Biol Blood Marrow Transplant.2011 Oct;17(10):1481-1489.Nash RA, McSweeney PA, Crofford LJ, et al. High dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe system sclerosis: long term follow-up of the US multicenter pilot study.Blood.2007;110(4):1388-1396.NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non-Hodgkins Lymphomas Version 3.2016. Adult T-Cell leukemia/lymphoma page TCEL-1 (~ p128) and Mycosis Fungoides/Sezary Syndrome page MFSS-1 (~ p105).Orsini E, Guarini A, Chiaretti S, Mauro FR, Foa R. The circulating dendritic cell compartment in patients with chronic lymphacytic leukemia is severely defective and unable to stimulate an effective T-cell response.Cancer Research.2003;(63):4497-4506.Oyama Y, Barr WG, Statkute L, et al. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis.Bone Marrow Transplant.2007;40(6):549-555.Oyama Y, Sufit R, Loh Y, et al. Autologous non-myeloablative hematopoietic stem cell transplantation for refractory CIDP.Neurology.2007:69(18):1802-1803.Ritgen M, Lange A, Stilgenbauer S, et al. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.Blood.2003;101(5):2049-2053.Rodrquez J, Conde E, Gutirrez A, et al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.Annals of Oncology.2007 Apr;18(4):652-657.Rosa SB, Voltarelli JC, Chies JA, Pranke P. The use of stem cells for the treatment of autoimmune diseases.Braz J Med Biol Res.2007;40(12):1579-1597.Snowden JA, Passweg J, Moore JJ, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.J Rheumatol.2004;31(3):482-488.Statkute L, Oyama Y, Barr WG, et al. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory system vascuitis.Ann Rheum Dis.2008;67:991-997.Statkute L, Traynor A, Oyama Y, et al. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation.Blood.2005;106(8):2700-2709.Teng YK, Verburg RJ, Sont JK, van den hout WB, Breedveld FC, van Laar JM. Long-term followup of health status in patients with severe rheumatoid arthritis after high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation.Arthritis Rheum.2005;52(8):2272-2276.Traynor AE, Corbridge TC, Eagan AE, et al. Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation.Chest.2005;127(5):1680-1689Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.JAMA.2007;297(14):1568-1576.Vonk MC, Marjanovic Z, van den Hoogen FH, et al. Long-term follow-up results after haematopoietic stem cell transplantation for severe systemic sclerosis.Ann Rheum Dis.2008;67(1):98-104.